LEARNER RECORDS: EVALUATION You must complete the program evaluation and applicable activity evaluation(s) in order to earn AMA PRA Category 1 Credits TM , MOC points, or participation in MIPS. For each of the objectives determine if the activity increased your: A Competence B Performance C Outcome D No Change
COURSE 1 - SUBSTANCE USE DISORDERS: A DEA REQUIREMENT
A B C D
1. Discuss substance use disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2. Describe the roles of the U.S. Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), and Department of Health and Human Services (HHS) in scheduling controlled substances and enforcing controlled substance laws and regulations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . 3. Understand the different DEA Controlled Substance Schedules and prescribing regulations associated with the different DEA Controlled Substance Schedules. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4. Review medical marijuana legislation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5. Describe essential considerations when prescribing controlled substances, including regulatory exceptions and clinical concerns. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6. Describe controlled substance prescribing practices.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7. Understand the treatment options for patients suffering from substance use disorder (SUD).. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8. Please identify a specific change, if any, you will make in your practice related to substance abuse disorders.
9. What do you see as a barrier to making these changes?
COURSE 2 - BEST PRACTICES FOR TREATING PAIN WITH OPIOID ANALGESICS:
A B C D
10. Identify and employ a full range of therapeutic options when developing a pain treatment plan.. . . . . . . . . . . . . . . . . . . . . . . . . . . 11. Screen patients for presence or risk of OUD, assess and manage patients who demonstrate signs of OUD, or refer if necessary. . 12. Please identify a specific change, if any, you will make in your practice related to safe prescribing of opioid analgesics.
13. What do you see as a barrier to making these changes?
COURSE 3 - MEDICAL ERRORS AND THE UNITED STATES HEALTHCARE SYSTEM: 14. Conduct appropriate root cause analysis of medical errors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15. Utilize strategies for the prevention and reduction of medical errors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16. Please identify a specific change, if any, you will make in your practice related to reducing medical errors.
A B C D
17. What do you see as a barrier to making these changes?
COURSE 4 - INTIMATE PARTNER VIOLENCE: COMPASSIONATE CARE, EFFECTIVE ASSESSMENT:
A B C D
18. Identify the barriers that prevent effective and compassionate care of potential survivors of IPV between patient and physicians. 19. Utilize patient interviewing techniques in situations where IPV is suspected . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20. Please identify a specific change, if any, you will make in your practice related to intimate partner violence.
21. What do you see as a barrier to making these changes?
OVERALL PROGRAM:
Yes No If no, please explain:
22. The program was balanced, objective & scientifically valid . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23. Do you feel the program was scientifically sound & free of commercial bias or influence? .
24. How can this program be improved?
25. Based on your educational needs, please provide us with suggestions for future program topics & formats.
26. For which activities would you like to use your participation as a clinical practice improvement activity (CPIA) for MIPS? Course 1 Course 2 Course 3 Course 4 None
63
Powered by FlippingBook